Free website hits

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of Zoom calls and deadlines has returned, along with a spot of snow in our neck of the world. Before continuing, we apologize for the late arrival this morning, but we encountered a bit of a problem here on the Pharmalot campus that required our attention. Now, though, we are focused on the matters at hand. So here are a few tidbits to start the day. We hope all goes well and you conquer the world. …

AstraZeneca (AZN) chief executive Pascal Soriot promised to churn out more Covid-19 vaccines, at a lower price, than any of his rivals, The Wall Street Journal writes. Now, a production problem at a single factory in Belgium has delayed tens of millions of doses destined for Europe, endangering the continent’s already-slow inoculation drive and representing the greatest threat so far to his extraordinary pledge last year to vaccinate the world — and do so for no profit. After disclosing the European problem, the drug maker now says it has been troubleshooting similar production issues in recent weeks as far away as the U.S. and Australia.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What’s included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Source: STATNEWS.COM

Leave a Reply

ArabicChinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

[mc4wp_form id="449"]